Steady-state pharmacokinetics of bupropion SR in juvenile patients

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 44, Issue 4, 2005, Pages 349-357

  Daviss, W Burleson ^a   Perel, James M ^a   Rudolph, George R ^a   Axelson, David A ^a   Gilchrist, Richard ^a   Nuss, Sharon ^a   Birmaher, Boris ^a   Brent, David A ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Adolescence; Bupropion; Developmental pharmacokinetics; Metabolites

Indexed keywords

AMFEBUTAMONE; DRUG METABOLITE; ERYTHRO HYDROBUPROPION; HYDROXYBUPROPION; THREO HYDROBUPROPION; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ADOLESCENT; ANOREXIA; AREA UNDER THE CURVE; ARTICLE; ATTENTION DEFICIT DISORDER; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG METABOLISM; FEMALE; HUMAN; IRRITABILITY; MALE; MONOTHERAPY; MOOD DISORDER; PRIORITY JOURNAL; RACE DIFFERENCE; RESTLESSNESS; SCHOOL CHILD; SEX DIFFERENCE; SIDE EFFECT; SOMNOLENCE; STEADY STATE; SUSTAINED RELEASE PREPARATION;

EID: 15344347747     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.chi.0000153225.26850.26     Document Type: Article

References (16)

1. Ascher JA, Cole JO, Colin JN et al. (1995), Bupropion: a review of its mechanism of antidepressant activity. J Clin Psychiatry 56:395-401
2. Axelson DA, Perel JM, Birmaher B et al. (2002), Sertraline pharmacokinetics and dynamics in adolescents. J Am Acad Child Adolesc Psychiatry 41: 1037-1044
3. Barrickman LL, Perry PJ, Allen AJ et al. (1995), Bupropion versus methylphenidate in the treatment of attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 34:649-657
4. Clein PD, Riddle MA (1995), Pharmacokinetics in children and adolescents. Child Adolesc Psychiatr Clin N Am 4:59-76
5. Conners CK, Casat CD, Gualtieri CT et al. (1996), Bupropion hydrochloride in attention deficit disorder with hyperactivity. J Am Acad Child Adolesc Psychiatry 35:1314-1321
6. Davidson J (1989), Seizures and bupropion: a review. J Clin Psychiatry 50: 256-261
7. Daviss WB, Bentivoglio P, Racusin R, Brown KM, Bostic JQ, Wiley L (2001), Bupropion sustained release in adolescents with comorbid attention-deficit/ hyperactivity disorder and depression. J Am Acad Child Adolesc Psychiatry 40:307-314
8. DeVane CL, Laizure SC, Stewart JT et al. (1990), Disposition of bupropion in healthy volunteers and subjects with alcoholic liver disease. J Clin Psychopharmacol 10:328-332
9. Glod CA, Lynch A, Flynn E, Berkowitz C, Baldessarini RJ (2003), Open trial of bupropion SR in adolescent major depression. J Child Adolesc Psychiatr Nurs 16:123-130
10. Hesse LM, Venkatakrishnan K, Court MH et al. (2000), CYP2B6 mediates the in vitro hydroxylation of bupropion: potential drug interactions with other antidepressants. Drug Metab Dispos 28:1176-1183
11. Hsyu PH, Singh A, Giargiari TD, Dunn JA, Ascher JA, Johnston JA (1997), Pharmacokinetics of bupropion and its metabolites in cigarette smokers versus nonsmokers. J Clin Pharmacol 37:737-743
12. Kaufman J, Birmaher B, Brent D et al. (1997), Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 36:980-988
13. Settle EC (1998), Bupropion sustained release: side effect profile. J Clin Psychiatry 4:32-36
14. Stewart JJ, Berkel HJ, Parish RC et al. (2001), Single-dose pharmacokinetics of bupropion in adolescents: effects of smoking status and gender. J Clin Pharmacol 41:770-778
15. Tanner JM, Whitehouse RH (1976), Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch Dis Child 51:170-179
16. Wilens TE, Spencer TJ, Biederman J et al. (2001), A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults. Am J Psychiatry 158:282-288